��������

Maciej Walczak, CU Boulder associate professor of chemistry, won a $2 million NIH grant to investigate how certain sugars modify a brain protein associated with neurodegeneration.

New research shows that cancer cells can adapt in as little as one to two hours to new drugs called CDK2 inhibitors. The good news: Adding a second, widely available drug disables this workaround, squelching tumor growth.

An ancient, virus-like protein best known for its essential role in placental development may, when over-expressed, fuel ALS—aka Lou Gehrig's disease—and other neurodegenerative diseases, according to new research. The discovery opens the door to a new class of potential treatments.

A revolutionary technique for editing genomes, called CRISPR-Cas9, has already helped cure sickle cell disease in dozens of people. But it also raises ethical concerns, which a panel of preeminent scientists grappled with at an event on the CU Boulder campus.

A study led by a CU Boulder researcher finds that flavored tobacco products reduce the likelihood of cessation later, but researchers say more investigation is needed.

A new study led by Angela Bryan, a CU Boulder professor and cancer survivor, is among the first to assess how cannabis bought over the counter at dispensaries—rather than government-supplied or synthetic varieties—impacts cancer symptoms or chemotherapy side effects.

The study of 46 million births across nearly three decades is among the first to provide population-level statistical evidence of “obstetric racism,” a term coined recently to describe a concerning pattern of maltreatment of non-white pregnant women, including a disregard for their birthing wishes.

Imagine carrying a UV device in your backpack and pulling it out to disinfect your bus seat or restaurant table. A new CU Boulder study shows that using a technology called Far UV-C kills almost 100% of pathogens within a few seconds, without risk to human bystanders.

By inhibiting a protein that helps cancer cells repair themselves, scientists hope to develop new drugs that treat resistant tumors with fewer side effects.

A new “digital nose” created with Nobel Prize-winning CU technology can provide COVID-19 test results in less than one hour with excellent accuracy. It could ultimately be used for on-the-go virus testing, diagnosis of cancer and lung diseases and more.